Testicular germ cell sensitivity to TRAIL-induced apoptosis is dependent upon p53 expression and is synergistically enhanced by DR5 agonistic antibody treatment

Apoptosis

Volumn 11, Issue 12, 2006, Pages 2237-2250

  McKee, Chad M ^a   Ye, Yang ^b   Richburg, John H ^b  

^a Institute for Cellular and Molecular Biology   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Apoptosis; Death receptor 5 (DR5); GC 2spd (ts); Testis; TRAIL

Indexed keywords

ANTIBODY; DEATH RECEPTOR 5; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LINE; FLOW CYTOMETRY; GERM CELL; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RAT; SIGNAL TRANSDUCTION; SPERMATOCYTE; TEMPERATURE SENSITIVITY; TUMOR CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; APOPTOSIS; CELL MEMBRANE; CELLS, CULTURED; CYCLOHEXIMIDE; DIETHYLHEXYL PHTHALATE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; RATS; RATS, INBRED F344; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT PROTEINS; SOLUBILITY; SPERMATOCYTES; TESTIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845349483     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-0288-1     Document Type: Article

References (52)

1. Kimberley FC and Screaton GR (2004) Following a TRAIL update on a ligand and its five receptors. Cell Res 14:359-372
2. Wajant H, Gerspach J, Pfizenmaier K (2005) Tumor therapeutics by design: targeting and activation of death receptors. Cytokine Growth Factor Rev 16:55-76
3. Fulda S, Debatin KM (2004) Modulation of TRAIL signaling for cancer therapy. Vitam Horm. 67:275-290
4. Kelley SK, Ashkenazi A (2004) Targeting death receptors in cancer with Apo2L/TRAIL. Curr Opin Pharmacol 4:333-339
5. Mori E, Thomas M, Motoki K, Nakazawa K, Tahara T, Tomizuka K, Ishida I and S Kataoka. Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2. Cell Death Differ 11:203-207
6. Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4:139-63
7. Peter ME (2000) The TRAIL DISCussion: It is FADD and caspase-8!. Cell Death Differ 7:759-760
8. Wang S, El-Deiry WS (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22:8628-8633
9. Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP (2002) Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Blood 99:2162-2171
10. Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P (2000) Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J Biol Chem 275:24357-24366
11. Kreuz S, Siegmund D, Scheurich P, Wajant H (2001) NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling Mol Cell Biol 21:3964-3973
12. Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB, Krammer PH, Walczak H (2000) Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 60:553-559
13. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP, Zhou T (2001) Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7:954-960
14. Guo Y, Chen C, Zheng Y, Zhang J, Tao X, Liu S, Zheng D, Liu Y (2005) A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death. J Biol Chem 280:41940-1952
15. Richburg JH, Boekelheide K (1996) Mono-(2-ethylhexyl) phthalate rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol Appl Pharmacol 137:42-50
16. Giammona CJ, Sawhney P, Chandrasekaran Y, Richburg JH (2002) Death receptor response in rodent testis after mono-(2-ethylhexyl) phthalate exposure. Toxicol Appl Pharmacol 185:119-127
17. Boekelheide K, Fleming SL, Johnson KJ, Patel SR, Schoenfeld HA (2000) Role of Sertoli cells in injury-associated testicular germ cell apoptosis. Proc Soc Exp Biol Med 225:105-115
18. Chandrasekaran Y, Richburg JH (2005) The p53 Protein Influences the Sensitivity of Testicular Germ Cells to Mono-(2-Ethylhexyl) Phthalate-Induced Apoptosis by Increasing the Membrane Levels of Fas and DR5 and Decreasing the Intracellular Amount of c-FLIP. Biol Reprod 72:206-213
19. Grataroli R, Vindrieux D, Gougeon A, Benahmed M (2002) Expression of Tumor Necrosis Factor-alpha-Related Apoptosis-Inducing Ligand and Its Receptors in Rat Testis During Development. Biol Reprod 66:1707-1715
20. Richburg JH, Nanez A, Williams LR, Embree ME, Boekelheide K (2000) Sensitivity of testicular germ cells to toxicant-induced apoptosis in gld mice that express a nonfunctional form of Fas ligand. Endocrinology 141:787-793
21. Chandrasekaran Y, McKee CM, Ye Y, Richburg JH (2006) Influence of TRP53 status on FAS membrane localization, CFLAR (c-FLIP) ubiquitinylation, and sensitivity of GC-2spd (ts) cells to undergo FAS-mediated apoptosis. Biol Reprod 74:560-568
22. Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, MJ Smyth (2002) Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice. J Immunol 168:1356-1361
23. Finnberg N, Gruber JJ, Fei P, Rudolph D, Bric A, Kim S, Burns TF, Ajuha H, Page R, Wu G, Chen Y, McKenna WG, Bernhard E, Lowe S, Mak T, El-Deiry WS (2005) DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis. Mol Cell Bio 5:2000-2013
24. Kotaja N, Kimmins S, Brancorsini S, Hentsch D, Vonesch JL, Davidson I, Parvinen M, Sassone-Corsi P (2004) Preparation, isolation and characterization of stage-specific spermatogenic cells for cellular and molecular analysis. Nat Methods 3:249-254
25. Grataroli R, Vindrieux D, Selva J, Felsenheld C, Ruffion A, Decaussin M, Benahmed M (2004) Characterization of tumour necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in the adult human testis. Mol Hum Reprod 10:123-128
26. Kangasniemi M, Kaipia A, Mali P, Toppari J, Huhtaniemi I, Parvinen M (1990) Modulation of basal and FSH-dependent cyclic AMP production in rat seminiferous tubules staged by an improved transillumination technique. The Anatomical Record 227:62-76
27. Hofmann MC, Narisawa S, Hess RA, Millan JL (1992) Immortalization of germ cells and somatic testicular cells using the SV40 large T antigen. Exp Cell Res 201:417-35
28. Hofmann M-C, Hess rA, Goldberg E, Millán JL (1994) Immortalized germ cells undergo meiosis in vitro. Proc Natl Acad Sci USA 91:5533-5537
29. Van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9
30. Jin Z, McDonald ER, 3rd, Dicker DT, El-Deiry WS (2004) Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279:35829-35839
31. Toppari J, Parvinen M (1985) In vitro differentiation of rat seminiferous tubular segments from defined stages of the epithelial cycle morphologic and immunolocalization analysis. J Androl 6:334-343
32. Bhattacharya N, Dufour JM, Vo MN, Okita J, Okita R, Kim KH (2005) Differential effects of phthalates on the testis and the liver. Biol Reprod 72:745-754
33. Takeda K, Yamaguchi N, Akiba H, Kojima Y, Hayakawa Y, Tanner JE, Sayers TJ, Seki N, Okumura K, Yagita H, Smyth MJ (2004) Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. J Exp Med 199:437-448
34. Bhojani MS, Rossu BD, Rehemtulla A (2003) TRAIL and antitumor responses. Cancer Biol Ther 2(4 Suppl 1):71-78
35. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155-162
36. Lee J, Richburg JH, Shipp EB, Meistrich ML, Boekelheide K (1999) The Fas system, a regulator of testicular germ cell apoptosis, is differentially up-regulated in Sertoli cell versus germ cell injury of the testis. Endocrinology 140:852-885
37. Schwartz D, Goldfinger N, Rotter V (1993) Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 8:1487-94
38. Yin Y, DeWolf WC, Morgentaler A (1997) p53 is associated with the nuclear envelope in mouse testis. Biochem Biophys Res Commun 235:689-694
39. Brooks CL, Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21:307-15
40. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416:648-653
41. Wang YL, Liu W, Sun YJ, Kwon J, Setsuie R, Osaka H, Noda M, Aoki S, Yoshikawa Y, Wada K (2006) Overexpression of ubiquitin carboxyl-terminal hydrolase L1 arrests spermatogenesis in transgenic mice. Mol Reprod Dev 73:40-49
42. Kwon J, Mochida K, Wang YL, Sekiguchi S, Sankai T, Aoki S, Ogura A, Yoshikawa Y, Wada K (2005) Ubiquitin C-terminal hydrolase L-1 is essential for the early apoptotic wave of germinal cells and for sperm quality control during spermatogenesis. Biol Reprod 73:29-35
43. Shen H, Sikorska M, Leblanc J, Walker PR, Liu QY (2006) Oxidative stress regulated expression of Ubiquitin Carboxyl-terminal Hydrolase-L1: Role in cell survival. Apoptosis. (In Press)
44. Print CG, Loveland KL (2000) Germ cell suicide: new insights into apoptosis during spermatogenesis. Bioessays 22:423-430
45. Richburg JR (2006) The role of death receptor signaling in testicular germ-cell apoptosis by mono-(2-ethylhexyl) phthalate(MEHP)-induced Sertoli cell injury and its implications for risk assessment. J Tox Environ Health 69:793-809
46. Wolkowicz MJ, Coonrod SA, Reddi PP, Millan JL, Hofmann MC, Herr JC (1996) Refinement of the differentiated phenotype of the spermatogenic cell line GC-2spd(ts). Biol Reprod 55:923-932
47. Ohtsuka T, Buchsbaum D, Oliver P, Makhija S, Kimberly R, Zhou T (2003) Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene 22:2034-2044
48. Buchsbaum DJ, Zhou T, Grizzle WE, Oliver PG, Hammond CJ, Zhang S, Carpenter M, LoBuglio AF (2003) Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Clin Cancer Res 9:3731-3741
49. Ichikawa K, Liu W, Fleck M, Zhang H, Zhao L, Ohtsuka T, Wang Z, Liu D, Mountz JD, Ohtsuki M, Koopman WJ, Kimberly R, Zhou T (2003) TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J Immunol 171:1061-1069
50. Peter ME, Scaffidi C, Medema JP, et al. (1999-1998) The death receptors. Results Probl Cell Differ 23:25-63
51. Febs Lett 424:41-45
52. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579-5588